Few patients at risk for common high blood pressure disorder receive screening
Only 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and
Read moreOnly 3% of patients at high risk for primary aldosteronism (PA), a common disorder that causes high blood pressure and
Read moreNearly one-third of adults age 65 and older who take thyroid hormone also take medications that are known to interfere
Read moreNew research is shedding light on how dementia can increase people’s risk for developing COVID-19, particularly among two groups: African
Read moreAdvanced kidney cancer patients could see their life expectancy DOUBLE with pioneering new two-in-one drug treatment Renal cell carcinoma is
Read moreAdministering zinc supplements to COVID-19 patients with low levels of this element may be a strategy to reduce mortality and
Read moreEpilepsy is one of the most common neurological conditions, affecting more than 65 million worldwide. For those dealing with epilepsy,
Read moreTARRYTOWN, N.Y. and PARIS, exelon drug interactions Feb. 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
Read moreA breakthrough study has found that palliative-focused care is better placed than radiotherapy to maintain quality of life for people
Read moreA recent study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients
Read moreFor many, it's unimaginable: the conversation that a health care worker must have with a patient who has a case
Read more